Since winter 2023–2024, Omicron JN.1 lineage strains of SARS-CoV-2, including the JN.1 and the KP.2 strain, have been widely circulating in the United States. Recommendations for the 2024–2025 Novavax ...
Dr. Robert Jacobson, medical director for Mayo Clinic's Primary Care Immunization Program, clears up some misconceptions about COVID-19 and the flu. "You aren't going to get the flu from the flu ...
If you missed the early fall push for flu and COVID-19 vaccines, it's not too late. Health officials say it's important to get vaccinated ahead of the holidays, when respiratory bugs tend to spread ...
2024-2025 COVID-19 vaccines reduced hospitalization risk by 40% against JN.1 lineage variants. COVID-19 is still a public threat and health concern. Between 2024 and 2025, an estimated 380,000 to ...
On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer/BioNTech and Moderna, for ages 6 months and up. About a week later, the ...
A major new study examining the 2023-2024 COVID-19 vaccines shows moderate protection that works best in the first few months but weakens considerably over time. The research, published in JAMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results